The National Science Foundation (NSF) awarded a $274,274 Small Business Innovation Research (SBIR) Phase I project grant to X-Cor Therapeutics Inc. The grant supports the development of a novel extracorporeal system to remove excess carbon dioxide from the blood of patients with chronic obstructive pulmonary disease (COPD). The project aims to optimize a "respiratory dialysis" prototype that can provide carbon dioxide removal to treat hypercapnic respiratory failure, reduce the need for mechanical ventilation, and improve patient outcomes while lowering hospitalization costs. Key objectives include developing a specialized dialysate to efficiently capture bicarbonate from the blood while minimizing waste, and implementing a dialysate recirculation loop to reduce overall usage. This award is funded through the NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, which supports early-stage R&D of innovative technologies across scientific and engineering domains.
Generated 3/18/25, 3:10 AM